1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND USING THEM FOR TREATING BACTERIAL INFECTIONS
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to compounds of formula (I), producing and using them in preventing or treating a bacterial infection.is formula (I), wherein Rrepresents (a) hydrogen, (b) (CO)-R, (c) COORor (d) COCHCOR, n is equal to 0, 1 or 2; Rrepresents (a) SOM, (b) SONH, (c) CHCOOM or (d) CFCOOM; M represents hydrogen or a cation; Rrepresents (a) hydrogen, (b) C-C-alkyl optionally substituted by one or more substitutes independently specified in halogen, OR, CN, CONRR, NRR, heterocyclyl, heteroaryl or aryl, (c) NRR, (d) CONRR, (e) heterocyclyl substituted by one or more substitutes independently specified in OR, NRR, halogen, CONRR, SO-alkyl, or NHC(NH)NRR, (f) heteroaryl optionally substituted by one or more substitutes independently specified in NRR, or CONRR, or (g) OR; Rrepresents (a) hydrogen or (b) C-C-alkyl; each Rand Rindependently represent (a) hydrogen or (b) C-C-alkyl optionally substituted by one or more substitutes independently specified NRRor heterocyclyl; each Rand Rindependently represent (a) hydrogen or (b) Rand Rare attached to each other to form a four- to seven-merous ring.EFFECT: producing the compounds for preventing or treating a bacterial infection.36 cl, 8 tbl, 52 ex.
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Europäisches Patentamt - (2016) vom: 27. März Zur Gesamtaufnahme - year:2016 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
PATEL MAKHESH VITKHALBKHAJ [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2016-03-27, Last update posted on www.tib.eu: 2022-11-24, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
RU2578370 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA005343364 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA005343364 | ||
| 003 | DE-627 | ||
| 005 | 20230504111203.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210529s2016 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA005343364 | ||
| 035 | |a (EPA)RU2578370 | ||
| 035 | |a (EPA)54289195 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a PATEL MAKHESH VITKHALBKHAJ |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND USING THEM FOR TREATING BACTERIAL INFECTIONS |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2016-03-27, Last update posted on www.tib.eu: 2022-11-24, Last updated: 2023-02-09 | ||
| 520 | |a FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to compounds of formula (I), producing and using them in preventing or treating a bacterial infection.is formula (I), wherein Rrepresents (a) hydrogen, (b) (CO)-R, (c) COORor (d) COCHCOR, n is equal to 0, 1 or 2; Rrepresents (a) SOM, (b) SONH, (c) CHCOOM or (d) CFCOOM; M represents hydrogen or a cation; Rrepresents (a) hydrogen, (b) C-C-alkyl optionally substituted by one or more substitutes independently specified in halogen, OR, CN, CONRR, NRR, heterocyclyl, heteroaryl or aryl, (c) NRR, (d) CONRR, (e) heterocyclyl substituted by one or more substitutes independently specified in OR, NRR, halogen, CONRR, SO-alkyl, or NHC(NH)NRR, (f) heteroaryl optionally substituted by one or more substitutes independently specified in NRR, or CONRR, or (g) OR; Rrepresents (a) hydrogen or (b) C-C-alkyl; each Rand Rindependently represent (a) hydrogen or (b) C-C-alkyl optionally substituted by one or more substitutes independently specified NRRor heterocyclyl; each Rand Rindependently represent (a) hydrogen or (b) Rand Rare attached to each other to form a four- to seven-merous ring.EFFECT: producing the compounds for preventing or treating a bacterial infection.36 cl, 8 tbl, 52 ex | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a DESHPANDE PRASAD KESHAV |4 aut | |
| 700 | 0 | |a BKHAVSAR SATISH |4 aut | |
| 700 | 0 | |a BKHAGVAT SACHIN |4 aut | |
| 700 | 0 | |a DZHAFRI MOKHAMMAD ALAM |4 aut | |
| 700 | 0 | |a MISHRA AMIT |4 aut | |
| 700 | 0 | |a PAVASE LAKSMIKANT |4 aut | |
| 700 | 0 | |a GUPTA SUNIL |4 aut | |
| 700 | 0 | |a KALE RADZHESH |4 aut | |
| 700 | 0 | |a DZHOSHI SANDZHIV |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2016) vom: 27. März |
| 773 | 1 | 8 | |g year:2016 |g day:27 |g month:03 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/54289195/publication/RU2578370A1?q=RU2578370 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2016 |b 27 |c 03 |
| 951 | |a AR | ||
| 952 | |j 2016 |b 27 |c 03 | ||